Insider Transactions Reported by 13 Insiders of Eledon Pharmaceuticals, Inc.

Symbol
ELDN on Nasdaq
Location
Irvine, CA

There are no Buy or Sell transactions made by insiders since 12 Feb 2025

Eledon Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
BVF PARTNERS L P/IL 10%+ Owner $3,632,225 29 Oct 2024
David-Alexandre C. Gros Chief Executive Officer, Director $1,574,402 10 Jan 2025
Steven Perrin President, Director $1,302,679 10 Jan 2025
Paul Little Chief Financial Officer $813,800 10 Jan 2025
Bryan E. Smith General Counsel, Corporate Sec $735,243 10 Jan 2025
GARY A. LYONS Director $421,670 01 May 2023
Walter Ogier Director $233,177 01 May 2023
Keith Katkin Director $12,948 10 Jan 2026
June Lee Director $5,179 10 Jan 2026
John S. McBride Director $5,179 10 Jan 2026
Allan Kirk Director $5,179 10 Jan 2026
Jan Hillson Director $5,179 10 Jan 2026
James A. Robinson Jr. Director $5,179 10 Jan 2026

Recent Insider Transactions by Companies or Individuals for Eledon Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.